Nephrology
Myth of the Month
IV fluid and narcotics for renal colic
From the Journals
Short-term NSAIDs appear safe for high-risk patients
The findings challenge the Choosing Wisely campaign of the American Society of Nephrology, which recommends against NSAIDs for high-risk patients...
From the Journals
Allopurinol reduces risk of renal decline in gout patients
Feature
Decision aid aims to make lupus nephritis treatment decisions more understandable
SMILE is the first tool of its kind for patients with lupus nephritis.
Conference Coverage
The VADT at 15 years: No legacy effect of intensive glucose control in T2DM
Final VADT follow-up study results show no legacy effect for CV or renal outcomes at 15 years in the intensive glucose therapy arm.
Conference Coverage
Abatacept loses ALLURE in lupus nephritis
Conference Coverage
Primary hPTH often goes unnoticed
Rates of undiagnosed primary hPTH at a kidney stone center were higher than expected, and about one in five cases could have been diagnosed before...
Conference Coverage
Testosterone therapy tied to kidney stone risk
Testosterone’s effect on kidney oxalate and citrate levels may drive the increased risk.
Conference Coverage
CKD triples risk of bad outcomes in HIV
BOSTON – Smoking, diabetes, dyslipidemia, low body mass index, and poor HIV control were modifiable risk factors for CKD.
Conference Coverage
CANVAS: Canagliflozin improved renal outcomes in diabetes
Austin, Tex. – This is in addition to reducing the risk of cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke.
From the Journals
Restrictive fluids tied to kidney injury after major abdominal surgery
Restricting fluids failed to improve disability-free survival, compared with a liberal fluid strategy.